dihexa hgf c-met cancer risk Developing pathway inhibitors for therapy: progress and challenges: Trends in Molecular Medicine Activated HGF-c-Met Axis in Head – HGF and MET: From Brain
HGF and MET: From Brain Development to Neurological Disorders PMC Targeting c MET Alterations in Cancer: A Review of Genetic Drivers and Therapeutic Implications Small molecule activation of the neurotrophin hepatocyte growth factor to treat Alzheimer disease The HGF c Met Axis: A Promising Therapeutic Target in Cancer Frontiers Research Topic
Pay in 4 interest-free payments of $6.99 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 2 - Aug 7



